Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia.
Dydrogesterone, similar to women's natural progesterone, has been used in a wide range of gynecological conditions. Despite its widespread use, dydrogesterone-induced hepatotoxicity and dydrogesterone-induced hemolytic anemia have, to the best of our knowledge, never been reported previously. We describe a case of hepatitis and warm antibody hemolytic anemia due to dydrogesterone.
Altintaş
Engin
E
Division of Gastroenterology, School of Medicine, Mersin University, Mersin, Turkey. enginaltintas@mersin.edu.tr
Oğuz
Dilek
D
Kaçar
Sabite
S
Ozderin
Yasemin
Y
Sezgin
Orhan
O
Zengin
Neslihan Inci
NI
D000208:Acute Disease; D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000628:therapy; D001707:Biopsy, Needle; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000628:therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004394:Dydrogesterone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008111:Liver Function Tests; D018570:Risk Assessment; D012720:Severity of Illness Index
D004394:Dydrogesterone